Positive Phase 1 results for SEP-631 show dose-dependent inhibition of skin wheal formation, complete at 10mg/day.205 characters.
The new drug SEP-631 has shown strong and dose-dependent inhibition of skin wheal formation induced by icatibant. At doses as low as 10 mg taken once daily, complete inhibition was achieved.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments